These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1322942

  • 1. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.
    Spinas GA, Keller U, Brockhaus M.
    J Clin Invest; 1992 Aug; 90(2):533-6. PubMed ID: 1322942
    [Abstract] [Full Text] [Related]

  • 2. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH, Gouma DJ, Buurman WA.
    J Immunol; 1993 Nov 15; 151(10):5554-62. PubMed ID: 8228246
    [Abstract] [Full Text] [Related]

  • 3. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.
    Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K.
    Hepatology; 2003 May 15; 37(5):1154-64. PubMed ID: 12717397
    [Abstract] [Full Text] [Related]

  • 4. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
    Steinshamn S, Bemelmans MH, Buurman WA, Waage A.
    Cytokine; 1995 Jan 15; 7(1):50-6. PubMed ID: 7749066
    [Abstract] [Full Text] [Related]

  • 5. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
    Matsiegui PB, Missinou MA, Issifou S, Necek M, Mavoungou E.
    Eur Cytokine Netw; 2007 Dec 15; 18(4):201-5. PubMed ID: 17964975
    [Abstract] [Full Text] [Related]

  • 6. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
    Vey E, Burger D, Dayer JM.
    Eur J Immunol; 1996 Oct 15; 26(10):2404-9. PubMed ID: 8898953
    [Abstract] [Full Text] [Related]

  • 7. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H, Ina Y, Ito S, Sato S, Sugiura Y, Tomita H, Ogisu N, Takada K, Yamamoto M, Morishita M, Yoshikawa K.
    Kekkaku; 1996 Mar 15; 71(3):259-65. PubMed ID: 8901228
    [Abstract] [Full Text] [Related]

  • 8. Detection of circulating tumor necrosis factor after endotoxin administration.
    Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW.
    N Engl J Med; 1988 Jun 09; 318(23):1481-6. PubMed ID: 2835680
    [Abstract] [Full Text] [Related]

  • 9. [Tumor necrosis factor-alpha system in patients with gestational diabetes].
    Kinalski M, Kuźmicki M, Telejko B, Bachórzewski R, Buraczyk M, Kretowski A, Kinalska I.
    Przegl Lek; 2006 Jun 09; 63(4):173-5. PubMed ID: 17083157
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes.
    Kinalski M, Telejko B, Kuźmicki M, Kretowski A, Kinalska I.
    Horm Metab Res; 2005 Jul 09; 37(7):450-4. PubMed ID: 16034719
    [Abstract] [Full Text] [Related]

  • 11. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
    van der Poll T, Jansen J, van Leenen D, von der Möhlen M, Levi M, ten Cate H, Gallati H, ten Cate JW, van Deventer SJ.
    J Infect Dis; 1993 Oct 09; 168(4):955-60. PubMed ID: 8397270
    [Abstract] [Full Text] [Related]

  • 12. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB.
    J Immunol; 1993 Aug 01; 151(3):1548-61. PubMed ID: 8393046
    [Abstract] [Full Text] [Related]

  • 13. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 01; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 14. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep 01; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 15. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B, van der Poll T, Levi M, van Deventer SJ, ten Cate H, Imai Y, Hack CE, ten Cate JW.
    J Immunol; 1994 Mar 01; 152(5):2438-46. PubMed ID: 8133055
    [Abstract] [Full Text] [Related]

  • 16. The effect of soluble tumor necrosis factor receptor-II on endotoxin-mediated hemodynamic instability.
    Anderson JA, Knott AW, Wilson MA, Garrison RN, Sims DE, Edwards MJ.
    J Surg Res; 1995 Jan 01; 58(1):53-7. PubMed ID: 7830406
    [Abstract] [Full Text] [Related]

  • 17. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.
    Godfried MH, van der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, van Deventer SJ, Sauerwein HP.
    AIDS; 1993 Jan 01; 7(1):33-6. PubMed ID: 8382926
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Gagetti O, Prontera C, Bianchi R, Facchini V.
    Gynecol Oncol; 1995 Aug 01; 58(2):184-8. PubMed ID: 7542621
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Prato B, Prontera C, Facchini V, Genazzani AR.
    Anticancer Res; 1996 Aug 01; 16(5B):3125-8. PubMed ID: 8920779
    [Abstract] [Full Text] [Related]

  • 20. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar 01; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.